Repositioning Candidates
Repositioning candidates for CKD are derived from DrugBank which fall into three categories: therapeutic strategy-associated, target-associated, and indication-associated candidates. For each candidate, detailed properties are extracted from DrugBank, and related strategies, target and CKD-associated disease in CKDdb are presented with knowledge graphs.
stats1
stats2
stats3
Search for:
antihypertensive15 records.
| Candidate ID | Source ID | Source Type | Compound Type | Candidate Name | Inclusion Criteria | |
|---|---|---|---|---|---|---|
| R0023 | DB00145 | approved; nutraceutical; vet_approved | small molecule | Glycine | Details | |
| R0024 | DB00146 | approved; nutraceutical | small molecule | Calcifediol | Details | |
| R0037 | DB00165 | approved; investigational; nutraceutical; vet_approved | small molecule | Pyridoxine | Details | |
| R0049 | DB00196 | approved; investigational | small molecule | Fluconazole | Details | |
| R0054 | DB00206 | approved; investigational | small molecule | Reserpine | Details | |
| R0075 | DB00282 | approved | small molecule | Pamidronic acid | Details | |
| R0083 | DB00313 | approved; investigational | small molecule | Valproic acid | Details | |
| R0084 | DB00316 | approved | small molecule | Acetaminophen | Details | |
| R0085 | DB00319 | approved | small molecule | Piperacillin | Details | |
| R0089 | DB00331 | approved | small molecule | Metformin | Details | |
| R0096 | DB00356 | approved | small molecule | Chlorzoxazone | Details | |
| R0123 | DB00438 | approved | small molecule | Ceftazidime | Details | |
| R0135 | DB00480 | approved | small molecule | Lenalidomide | Details | |
| R0136 | DB00482 | approved; investigational | small molecule | Celecoxib | Details | |
| R0178 | DB00626 | approved; vet_approved | small molecule | Bacitracin | Details |